Early Indication of Decompensated Heart Failure in Patients on Home-Telemonitoring: A Comparison of Prediction Algorithms Based on Daily Weight and Noninvasive Transthoracic Bio-impedance
Overview
Authors
Affiliations
Background: Heart Failure (HF) is a common reason for hospitalization. Admissions might be prevented by early detection of and intervention for decompensation. Conventionally, changes in weight, a possible measure of fluid accumulation, have been used to detect deterioration. Transthoracic impedance may be a more sensitive and accurate measure of fluid accumulation.
Objective: In this study, we review previously proposed predictive algorithms using body weight and noninvasive transthoracic bio-impedance (NITTI) to predict HF decompensations.
Methods: We monitored 91 patients with chronic HF for an average of 10 months using a weight scale and a wearable bio-impedance vest. Three algorithms were tested using either simple rule-of-thumb differences (RoT), moving averages (MACD), or cumulative sums (CUSUM).
Results: Algorithms using NITTI in the 2 weeks preceding decompensation predicted events (P<.001); however, using weight alone did not. Cross-validation showed that NITTI improved sensitivity of all algorithms tested and that trend algorithms provided the best performance for either measurement (Weight-MACD: 33%, NITTI-CUSUM: 60%) in contrast to the simpler rules-of-thumb (Weight-RoT: 20%, NITTI-RoT: 33%) as proposed in HF guidelines.
Conclusions: NITTI measurements decrease before decompensations, and combined with trend algorithms, improve the detection of HF decompensation over current guideline rules; however, many alerts are not associated with clinically overt decompensation.
La Porta E, Faragli A, Herrmann A, Lo Muzio F, Estienne L, Nigra S J Clin Med. 2024; 13(21).
PMID: 39518641 PMC: 11546501. DOI: 10.3390/jcm13216502.
Faragli A, Herrmann A, Cvetkovic M, Perna S, Khorsheed E, Lo Muzio F Clin Res Cardiol. 2024; .
PMID: 39495329 DOI: 10.1007/s00392-024-02571-7.
Recent Advances in the Wearable Devices for Monitoring and Management of Heart Failure.
Odeh V, Chen Y, Wang W, Ding X Rev Cardiovasc Med. 2024; 25(10):386.
PMID: 39484130 PMC: 11522764. DOI: 10.31083/j.rcm2510386.
Wearable Devices Based on Bioimpedance Test in Heart Failure: Clinical Relevance: Systematic Review.
Gimenez-Miranda L, Scagliusi S, Perez-Garcia P, Olmo-Fernandez A, Huertas G, Yufera A Rev Cardiovasc Med. 2024; 25(9):315.
PMID: 39355607 PMC: 11440438. DOI: 10.31083/j.rcm2509315.
Wearable Bioimpedance Monitoring: Viewpoint for Application in Chronic Conditions.
Groenendaal W, Lee S, Van Hoof C JMIR Biomed Eng. 2024; 6(2):e22911.
PMID: 38907374 PMC: 11041432. DOI: 10.2196/22911.